ArticleTrials2020

A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer.

Min Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.